Project Grant R41GM164306
Award Date 9/11/25
Completion Date 8/31/26
Dollars Obligated $307K
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Loma Linda, CA 92354, USA
Similar Awards
- This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), is for the development of an endovascular prosthetic graft device that integrates nitric oxide (NO)-releasing polymer technology. The goal is to create a device that can reduce the incidence of infection, neointimal proliferation, and thrombosis - the three main clinical complications associated with current endovascular stent grafts. The total funding...
- This federal Project Grant award of $349,566 from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports the development of a Spotting-Free Nano-Oscillator Array (SFNOA) technology for high-throughput, label-free quantification of ligand binding kinetics to transmembrane proteins in their native states. The key products and services delivered through this award include: Integration of innovative technologies...
- The federal Project Grant award, totaling $448,250.00, was granted by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to support the development of sulfonium lipid nanoparticles (SLNPs) as a novel platform for mRNA delivery. The primary objective is to expand the chemical diversity of sulfonium lipids, investigate their unique physicochemical and biological properties, and explore the therapeutic potential of...
- This federal Project Grant award of $324,998 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training (CFDA 93.859) program supports Rejuvenation Technologies Inc. (RTI) in developing advanced therapeutic technologies for in vivo delivery of mRNA to stem and progenitor cells. The key objectives of this award are to: 1) generate a library of rationally designed peptides for targeting three progenitor cell types, 2) utilize computational...
- This federal Project Grant award of $306,867 from the National Institute of General Medical Sciences (CFDA 93.859 Biomedical Research and Research Training program) supports the project "RAPID CONTROL AND ASSESSMENT OF DISSOLVED GAS SIGNALS ON TISSUE FUNCTION AND DISEASE" at Entox Sciences, Inc. in Seattle, WA. The project aims to develop instrumentation and methods to rapidly control and assess the effects of biologically important gases, including hydrogen sulfide, nitric oxide,...
- This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to develop GPR139 antagonists for the treatment of pain. The $603,406 award to Research Triangle Institute (RTI International) aims to optimize the potency, selectivity, and drug-like properties of GPR139 antagonists through medicinal chemistry, and then evaluate...
- The National Science Foundation awarded Medchem Partners LLC a $256,000 Project Grant under the Engineering federal grant program (CFDA 47.041) for the period of August 1, 2021 through July 31, 2022. The grant funds the development of novel inhaled nitric oxide therapy for pulmonary treatments related to COVID-19. The Engineering program seeks to improve quality of life and economic strength through engineering research and innovation. This award supports Medchem Partners' work advancing new...
- This Project Grant award, ID R35GM156443, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The $419,375 award, spanning January 1, 2025 to November 30, 2029, supports research at the University of New Mexico Health Sciences Center (UNM HSC) to define the functional dynamics of multidomain redox enzymes, with a focus on nitric oxide synthase (NOS) enzymes. The research aims to gain a comprehensive...
- The National Institute of General Medical Sciences (NIGMS) awarded a $218,622 Project Grant to Vitan-Biotech LLC on September 22, 2023 under the Biomedical Research and Research Training program (CFDA 93.859). The grant will fund the development of an integrated pipeline to rapidly discover and characterize selective, high-affinity nanobodies against defined G protein-coupled receptors (GPCRs) that are important for neurological disorders like schizophrenia, pain, Parkinson's, Alzheimer's, and...
- This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $303,024 to Biocognon LLC to develop an innovative combinatorial pipeline for discovering nanobody-based therapeutics targeting G-protein coupled receptors (GPCRs). The key products and services to be delivered under this award include: (1) developing a robust assembly system for GPCR and nanobody libraries, (2) building a...